Aspex Eyewear, Inc. v. E'Lite Optik, Inc.

552 F. Supp. 2d 620, 2008 U.S. Dist. LEXIS 27184, 2008 WL 898851
CourtDistrict Court, N.D. Texas
DecidedApril 3, 2008
Docket4:02-cv-00634
StatusPublished

This text of 552 F. Supp. 2d 620 (Aspex Eyewear, Inc. v. E'Lite Optik, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aspex Eyewear, Inc. v. E'Lite Optik, Inc., 552 F. Supp. 2d 620, 2008 U.S. Dist. LEXIS 27184, 2008 WL 898851 (N.D. Tex. 2008).

Opinion

MEMORANDUM OPINION AND ORDER

SIDNEY A. FITZWATER, Chief Judge.

Defendant-counterplaintiff E’Lite Optik, Inc. (“E’Lite”) moves for partial summary judgment on plaintiffs’ patent infringement claim. Because the court’s construction of United States Patent No. RE37 545E (“the '545 patent”) settles as a matter of law that both of E’Lite’s accused products did not infringe claims 18 and 23 of the '545 patent, the court grants E’Lite’s motion to the extent plaintiffs’ infringement suit is premised on either claim 18 or 23.

I

In 2002 plaintiffs-counterdefendants As-pex Eyewear, Inc. and Contour Optik, Inc. *622 (collectively, “Aspex”) sued E’Lite for infringement of the '545 patent. 1 The court stayed this lawsuit in 2003, and when the stay terminated in 2006, Aspex filed its opening claim construction brief, requesting that the court construe the disputed claim limitations of claims 18 and 23 of the '545 patent. Aspex restricted its infringement suit to these claims of the '545 patent, stating that “[t]o narrow the issues for trial and facilitate this claim construction process, Plaintiffs are asserting only claims 18 and 23 against E’Lite.” Ps. Claim Constr. Br. 3.

In October 2007 the court filed an opinion construing claims 18 and 23 of the '545 patent. See Aspex Eyewear, Inc. v. E’Lite Optik, Inc., 2007 WL 2984673, at *2, *18 (N.D.Tex. Oct. 12, 2007) (Fitzwater, J.) (“Aspex TV”). Based on Aspex IV, E’Lite moves for partial summary judgment, contending as a matter of law that both accused products — the “Smart Clip” frames and the “MacEye” frames — do not infringe claims 18 and 23. Aspex concedes in response that, based on the court’s construction of the '545 patent in Aspex IV, summary judgment is proper against it with respect to its allegations that E’Lite’s “Smart Clip” frames infringed claims 18 and 23 of the '545 patent. 2 Thus the only issue in this motion is whether summary judgment is proper with respect to Aspex’s infringement allegations directed at E’Lite’s “MacEye” frames.

II

“Summary judgment is generally appropriate where, after making all inferences in favor of the nonmoving party, there are no genuine issues of material fact and the moving party is entitled to judgment as a matter of law.” U.S. Philips Corp. v. Iwasaki Elec. Co., 505 F.3d 1371, 1374 (Fed.Cir.2007) (citing Fed. R.Civ.P. 56(c); Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986)). “ ‘Summary judgment on the issue of infringement is proper when no reasonable jury could find that every limitation recited in a properly construed claim either is or is not found in the accused device either literally or under the doctrine of equivalents.’ ” Id. at 1374-75 (quoting PC Connector Solutions LLC v. SmartDisk Corp., 406 F.3d 1359, 1364 (Fed.Cir.2005)).

E’Lite does not argue that its “MacEye” frames do not contain all the limitations of claim 18 or claim 23 of the '545 patent. Rather, E’Lite contends that it is entitled to summary judgment of noninfringement concerning its “MacEye” frames because it has neither made nor sold “MacEye” frames since 1998, and the effective date of the '545 patent is February 12, 2002, the *623 date the reissue patent was granted. E’Lite therefore maintains that even if the “MacEye” frames contain all of the limitations of claim 18 or 23, its production and sales of the “MacEye” frames could not have infringed claims 18 and 23 of the '545 patent because the reissue claims were not effective until E’Lite ceased any potentially infringing activity concerning the “Ma-cEye” frames. Alternatively, E’Lite posits that it is entitled to summary judgment based on the defense of intervening rights.

In support of its motion for summary judgment, E’Lite submits a declaration of Greg Smith, an officer and director of E’Lite, who avers that E’Lite

has not made, used, sold, offered for sale, or imported any product whatsoever since February 12, 2002 that used horizontally oriented magnets secured to the ends of arms or magnets that engage along a vertical polar axis and are secured to the ends of arms. All products of that type (arm-mounted magnets) sold by E’Lite Optik since that date have had magnets that are vertically oriented and horizontally engage.

D.App. 1-2. Based on this declaration and the court’s construction of the '545 patent that both claims 18 and 23 contain magnetic members with horizontal orientation, Aspex IV, 2007 WL 2984673, at *23, E’Lite contends that it is entitled to summary judgment concerning its “MacEye” frames.

Aspex does not rebut by evidence or argument the assertion that E’Lite did not engage in any infringing activity with respect to its “MacEye” frames after February 12, 2002, the day the '545 patent was issued. 3 Rather, Aspex’s sole basis for opposing E’Lite’s motion for partial summary judgment is that claim 18 of the '545 patent is substantially identical to claim 2 of the '545 patent’s predecessor, United States Patent No. 5,568,207 (“the '207 patent”). Therefore, Aspex maintains that under the first paragraph of 35 U.S.C. § 252, the effective date of claim 18 is October 22, 1996, the date the '207 patent was issued. Aspex contends that there is a genuine issue of material fact whether the “MacEye” frames infringed claim 18 of the '545 patent, even if no infringing activity occurred after February 12, 2002.

Ill

A

The first paragraph of 35 U.S.C. § 252 provides:

The surrender of the original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.

(emphasis added). “Applying [this paragraph of] § 252, when the reexamined or reissued claims are identical to those of *624

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
552 F. Supp. 2d 620, 2008 U.S. Dist. LEXIS 27184, 2008 WL 898851, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aspex-eyewear-inc-v-elite-optik-inc-txnd-2008.